2015
DOI: 10.1016/j.chemosphere.2014.07.088
|View full text |Cite
|
Sign up to set email alerts
|

Chlorpyrifos inhibits cell proliferation through ERK1/2 phosphorylation in breast cancer cell lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
25
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 59 publications
(25 citation statements)
references
References 30 publications
0
25
0
Order By: Relevance
“…However, another organophosphate, chlorpyrifos, which was associated with increased breast cancer risk in this study, has been observed to act as a potential endocrine disruptor in vivo ( Ventura et al 2016 ) and in vitro ( Andersen et al 2002 ), altering levels of circulating and bioavailable sex hormones ( Hodgson and Rose 2006 ). Chlorpyrifos also induces cell proliferation ( Ventura et al 2016 ), oxidative stress ( Ventura et al 2015 ), and genotoxicity ( Rahman et al 2002 ). However, a rodent bioassay of chlorpyrifos found no evidence of carcinogenicity ( Yano et al 2000 ).…”
Section: Discussionmentioning
confidence: 65%
“…However, another organophosphate, chlorpyrifos, which was associated with increased breast cancer risk in this study, has been observed to act as a potential endocrine disruptor in vivo ( Ventura et al 2016 ) and in vitro ( Andersen et al 2002 ), altering levels of circulating and bioavailable sex hormones ( Hodgson and Rose 2006 ). Chlorpyrifos also induces cell proliferation ( Ventura et al 2016 ), oxidative stress ( Ventura et al 2015 ), and genotoxicity ( Rahman et al 2002 ). However, a rodent bioassay of chlorpyrifos found no evidence of carcinogenicity ( Yano et al 2000 ).…”
Section: Discussionmentioning
confidence: 65%
“…Conventional MAPKs include p38 MAPK, extracellular signalregulated kinase 1 and 2 (ERK1/2), c-Jun N-terminal kinases/stress activated protein kinases (JNK/SAPK) and ERK5 [Arthur and Ley, 2013]. Activation of p38 MAPK [Galliher and Schiemann, 2007;Jiang et al, 2016] and ERK1/2 [Ventura et al, 2015;Liu et al, 2016] pathways are important for breast cancer cell proliferation. Sathya et al [2015] found that estrogen suppressed breast cancer proliferation through inhibiting p38 MAPK signaling pathway.…”
mentioning
confidence: 99%
“…However, two other studies did not find any chlorpyrifos-induced endocrine disrupting potential [ 47 , 48 ]. Chlorpyrifos was also found to alter changes in gene expression [ 46 ], induce cell cycle arrest in the S and G2/M-phase vent [ 49 ], decrease cell proliferation [ 50 ], and increase oxidative stress [ 51 ]. A detailed summary of the main findings and their proposed cellular mechanisms are shown in Table 3 .…”
Section: Resultsmentioning
confidence: 99%